| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.43 | 0.0002 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.82 | 0.0004 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |